Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.28 | 5e-17 |
mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.29 | 7e-17 |
mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.23 | 2e-15 |
mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.26 | 4e-15 |
mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.25 | 4e-14 |
mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.29 | 1e-13 |
mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.24 | 4e-13 |
mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.22 | 8e-13 |
mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.26 | 1e-12 |
mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.24 | 2e-12 |